Opioid rotation: does it have a role?

Abstract

Get full access to this article

View all access options for this article.

References

Chapman CR , Foley KM , eds. Changing concepts of tolerance to opioids. What the cancer patient has taught us. Current and emerging issues in cancer pain: research practice. New York: Raven Press, 1993: 331-50.

Bruera E. , Pereira J. , Watanabe S. et al. Opioid rotation in patients with cancer pain. A retrospective comparison of dose ratios between methadone, hydromorphone, and morphine. Cancer 1996; 78: 852-57.

Crews JC , Sweeney NJ , Denson DD Clinical efficacy of methadone in patients refractory to other mu-opioid receptor agonist analgesics for management of terminal cancer pain. Case presentations and discussion of incomplete cross-tolerance among opioid agonist analgesics. Cancer 1993; 72: 2266-72.

Fallon M. , Hanks Gwc. Opioid resistant pain in cancer: sense or nonsense. The Pain Clinic 1993; 6: 205-206.

Galer BS , Coyle N. , Pasternak GW , Portenoy RK Individual variability in the response to different opioids: report of five cases. Pain 1992; 49: 87-91.